Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Yves Agid »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yvan Vachez < Yves Agid < Yves Dauvilliers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 49.
[20-40] [0 - 20][0 - 49][40-48][40-60]
Ident.Authors (with country if any)Title
000513 (2001) Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice
000526 (2000) Boulos Paul Bejjani ; Isabelle Arnulf ; Marie Vidailhet ; Bernard Pidoux [France] ; Philippe Damier ; Savvas Papadopoulos ; Anne-Marie Bonnet ; Philippe Cornu ; Didier Dormont ; Yves Agid [France]Irregular jerky tremor, myoclonus, and thalamus: A study using low‐frequency stimulation
000534 (1999) Franck Durif [France] ; Marie Vidailhet [France] ; Bérangère Debilly [France] ; Yves Agid [France]Worsening of levodopa‐induced dyskinesias by motor and mental tasks
000545 (1999) Yves Agid [France] ; E. Ahlskog [France] ; A. Albanese [France] ; D. Calne [France] ; T. Chase [France] ; J. De Yebenes [France] ; S. Factor [France] ; S. Fahn [France] ; O. Gershanik [France] ; C. Goetz [France] ; W. Koller [France] ; M. Kurth [France] ; A. Lang [France] ; A. Lees [France] ; P. Lewitt [France] ; D. Marsden [France] ; E. Melamed [France] ; P. P. Michel [France] ; Y. Mizuno [France] ; J. Obeso [France] ; W. Oertel [France] ; W. Olanow [France] ; Werner Poewe [France] ; Pierre Pollak [France] ; S. Przedzorski [France] ; N. Quinn [France] ; R. Raisman-Vozari [France] ; A. Rajput [France] ; F. Stocchi [France] ; E. Tolosa [France]Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint
000547 (1999) Etienne C. Hirsch [France] ; Stéphane Hunot [France] ; Baptiste Faucheux [France] ; Yves Agid [France] ; Yoshikuni Mizuno [Japon] ; Hideki Mochizuki [Japon] ; William G. Tatton [États-Unis] ; Nadine Tatton [États-Unis] ; Warren C. Olanow [États-Unis]Dopaminergic neurons degenerate by apoptosis in Parkinson's disease
000551 (1999) Nada Sabbagh [France] ; Alexis Brice [France] ; Delphine Marez [France] ; Alexandra Dürr [France] ; Maryline Legrand [France] ; Jean-Marc Lo Guidice [France] ; Alain Destée [France] ; Yves Agid [France] ; Franck Broly [France]CYP2D6 Polymorphism and Parkinson's disease susceptibility
000553 (1999) M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
000557 (1999) P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France]Dyskinesias assessment in phase II studies
000563 (1998) Marie Vidailhet [France] ; Charles-Pierre Jedynak [France] ; Pierre Pollak [France] ; Yves Agid [France]Pathology of Symptomatic Tremors
000571 (1998) Bejjani [France] ; Philippe Damier [France] ; Isabelle Arnulf [France] ; Sawas Papadopoulos [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Yves Agid [France] ; Bernard Pidoux [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Claude Marsault [France]Deep brain stimulation in Parkinson's disease: Opposite effects of stimulation in the pallidum
000579 (1998) B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France]Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum
000581 (1997) Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and parkinson's disease: Clinical and urodynamic aspects
000592 (1997) A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
000599 (1996) Jean-Philippe Brandel [France] ; Marie Vidailhet [France] ; Geneviéve Noseda [France] ; Jean-Paul Harpey [France] ; Yves Agid [France]Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis
000608 (1995) Gouider‐Khouja [France] ; Marie Vidailhet [France] ; Anne-Marie Bonnet [France] ; Jacques Pichon [France] ; Yves Agid [France]“Pure” striatonigral degeneration and Parkinson's disease: A comparative clinical study
000619 (1995) Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine
000625 (1995) A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
000626 (1995) N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France]"Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study
000654 (1992) Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse]Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease
000656 (1992) Blin [France] ; M. Vidailhet [France] ; B. Pillon [France] ; Bruno Dubois [France] ; J. Feve [France] ; Yves Agid [France]Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET
000660 (1992) M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
37Humans
29Parkinson disease
23Middle Aged
22Male
21Aged
21Female
21Human
18Parkinson's disease
16Nervous system diseases
13Parkinson Disease (drug therapy)
10Adult
10Levodopa (adverse effects)
10Parkinson Disease (physiopathology)
8Antiparkinson Agents (adverse effects)
7Levodopa (therapeutic use)
7Treatment
6Antiparkinson Agents (therapeutic use)
6Deep brain stimulation
6Dose-Response Relationship, Drug
6Dyskinesia, Drug-Induced (etiology)
6Parkinson Disease (therapy)
6Severity of Illness Index
6Subthalamic nucleus
6deep brain stimulation
5Exploration
5Tremor
5Tremor (physiopathology)
5subthalamic nucleus
4Animals
4Antiparkinson agent
4Case-Control Studies
4Diagnosis, Differential
4Dyskinesia
4Follow-Up Studies
4Levodopa
4Neuropsychological Tests
4Parkinson Disease (pathology)
4Subthalamic Nucleus (physiology)
3Aged, 80 and over
3Antiparkinson Agents (administration & dosage)
3Chemotherapy
3Cognition Disorders (diagnosis)
3D1 Dopamine receptor
3Deep Brain Stimulation
3Degeneration
3Dopamine
3Dopamine agonist
3Dyskinesia, Drug-Induced (diagnosis)
3Indoles (therapeutic use)
3Magnetic Resonance Imaging
3Neurologic Examination (drug effects)
3Parkinson Disease (complications)
3Parkinson Disease (psychology)
3Parkinsonism
3Symptomatology
2Animal
2Brain (pathology)
2Brain (physiopathology)
2Bromocriptine (therapeutic use)
2Case study
2Comparative study
2Corpus Striatum (drug effects)
2Corpus Striatum (physiopathology)
2Corpus striatum
2Cross-Over Studies
2DNA Mutational Analysis
2Deep Brain Stimulation (methods)
2Dominance, Cerebral (physiology)
2Dopamine (physiology)
2Dopamine Agonists (therapeutic use)
2Dopamine agonists
2Double-Blind Method
2Drug Administration Schedule
2Drug Therapy, Combination
2Dyskinesia, Drug-Induced (physiopathology)
2Electric Stimulation Therapy
2Electrical stimulus
2Electrodes, Implanted
2Electromyography
2France
2Globus Pallidus (physiology)
2Immunohistochemistry
2Instrumentation therapy
2Involuntary movement
2Levodopa (administration & dosage)
2Levodopa (pharmacokinetics)
2Levodopa (pharmacology)
2Long term
2Mesencephalon (pathology)
2Mutation
2Myoclonus (physiopathology)
2Nerve Degeneration
2Nerve Degeneration (physiology)
2Nigrostriatal pathway
2Parkinson Disease, Secondary (chemically induced)
2Parkinson Disease, Secondary (diagnosis)
2Parkinsonian Disorders (genetics)
2Parkinsonian Disorders (therapy)
2Pathogenesis
2Pathophysiology

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Yves Agid" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Yves Agid" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Yves Agid
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024